Target Audience

Disclosure Statement (CM 2558)

CDC, our planners, our presenters and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Daskalakis’, Mr. Huyett’s and Dr. Rompalo’s discussion on oropharyngeal and anorectal NAAT testing, pap testing, PEP treatment, nifedipine ointment, imiquimod, Gardasil and meningococcal vaccine. They will be discussing: 1. oropharyngeal and anorectal NAAT testing for chlamydia and gonorrhea and can only be conducted at laboratories that have done the appropriate quality assurance validation testing; 2. Annual Anal pap testing for HIV+ MSM is not FDA approved for men; 3. The treatments listed for PEP are FDA approved for HIV but not for PEP use; 4. The Meningococcal vaccine recommendation for MSM and HIV+ MSM is not ACIP recommendation but a NYC DOHMH recommendation. 5. Providing Gardasil outside of the age recommendations to prevent anal cancer 6. Providing Nifedipine ointment to apply fissures 7. Using Imiquimod with a different dosing strata for people who are immune compromised.

Continuing Education

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

Please note that participants must complete the online evaluation and continuing education forms by Monday July 20th.

If you are experience difficulties accessing your CE, you may contact CDC's Training and Continuing Education Online (TCEO) support at 1-800-4TRAIN, via email or ce@cdc.gov, or through theirlearner support contact form.